Latest: FDA Approves New Biosimilar for Oncology Treatment

STAT+: Cytokinetics drug yielded benefits over common therapy in patients with heart condition, study shows

0 Mins
An experimental medicine from Cytokinetics showed strong results in patients newly diagnosed with a common, inherited heart condition, according to new study results.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago